IL6 and uveitis: In addition to its anti-inflammatory effects, research has demonstrated that inhibition of IL-6 significantly improves uveitic macular edema, which has raised considerable interest among ophthalmic specialists regarding the therapeutic potential of TCZ in the treatment of uveitis [7,16,49].